Combine two existing technologies into a single RT-qPCR system for detection and characterization of SARS-CoV-2
Improve the detection of COVID-19 in clinical samples by adapting your workflow. During this time of crisis and constrained supply chains, having alternative sources of critical assay components is crucial. Rapid shifting to improved workflows to improve COVID-19 testing helps with rapid infection containment, minimizing the impact of disease pathology on the wider population, and limiting pressure on national health care systems.
Download this application note to learn how to combine reagents from LGC, Biosearch Technologies™ for detection and characterization of SARS-CoV-2.
